Breakthrough Victoria invests $800,000 in Melbourne’s Diag-Nose.io to advance respiratory health
Breakthrough Victoria has invested $800,000 in Diag-Nose.io Medical (DNM), a Melbourne-based innovator in respiratory healthcare, to enhance clinical management and drug discovery for chronic respiratory diseases globally. Originally launched from Stanford’s ENT Innovation Program and now headquartered in Notting Hill, Melbourne, Diag-Nose.io is revolutionising the treatment of chronic respiratory diseases (CRDs) like asthma and COPD,…